People's Health Press
ISSN 2096-2738 CN 11-9370/R

Source Journal for Chinese Scientific and Technical Papers and Citations
Source Journal for Annual Report for Chinese Academic Journal Impact Factors(2022)
Indexed Journals in the Database of the Chemical Abstracts Service (CAS), USA
Indexed Journals in the Database of the Japan Science and Technology Agency (JST)

  • Official WeChat

  • Official Weibo

  • Official headlines

Information

LinksMore>

Epidemic Information

    Notice! 16 Key Numbers to Understand COVID-19 Vaccines
  • As of now, China has administered 1.3 billion doses of COVID-19 vaccines, but due to its large population base, the vaccination rate remains much lower than in countries like the UK and the US. Herd immunity is only achieved when 70–80% of the population is vaccinated. How long should the two doses of inactivated vaccines be spaced? Who should not get vaccinated? Can different COVID-19 vaccines be used interchangeably? Here’s a quick overview of 16 key data points about vaccination—save for reference!

    16 Key Numbers for COVID-19 Vaccination:

    1. 1.3 billion doses administered in China as of [date], covering ~9.2% of the population (calculated by doses per 100 people).
    2. 70–80% target: Herd immunity threshold for COVID-19, requiring 980 million–1.12 billion people vaccinated in China (based on a population of 1.4 billion).
    3. 21–28 days: Recommended interval between two doses of inactivated vaccines (e.g., Sinopharm, Sinovac).
    4. 4–8 weeks: Interval for adenovirus vector vaccines (e.g., CanSinoBIO), typically a single dose but some regimens may require two.
    5. 18+: Eligibility for most vaccines in China; trials for adolescents (12–17 years) are ongoing.
    6. 40 million+: Daily global vaccination capacity (as of mid-2021), with China contributing ~25% of daily doses.
    7. <3 days: Average time for adverse reactions (e.g., soreness, fever) to subside after vaccination.
    8. 90%+: Efficacy of mRNA vaccines (Pfizer/BioNTech, Moderna) against symptomatic infection; ~79% for Chinese inactivated vaccines.
    9. 14 days: Time required after the second dose for full protective effects to develop.
    10. Contraindications: Individuals with severe allergies, uncontrolled chronic diseases, or acute infections should not be vaccinated.
    11. 2–3 weeks: Minimum gap recommended between COVID-19 vaccines and other vaccines (e.g., flu shots).
    12. 0%: Vaccination is not recommended for pregnant women (data on safety during pregnancy is still emerging).
    13. 7 days: Wait period after recovering from COVID-19 before getting vaccinated.
    14. No: Different technical platforms (inactivated, mRNA, vector) are not interchangeable unless specified by health authorities.
    15. 2–8°C: Storage temperature for most inactivated vaccines, contrasting with mRNA vaccines requiring ultra-cold storage (-20°C to -70°C).
    16. 10 billion+: Global vaccine doses administered by end of 2021, with China accounting for ~25% of the total.

    Note: Specific guidelines may vary by region. Always consult local health authorities or your physician before vaccination.
  • 2021-04-07 Visited: 1067